Last reviewed 2026-04-20 · How we verify

Tacrolimus Pill

Edward Geissler · FDA-approved active Small molecule Quality 5/100

At a glance

Generic name	Tacrolimus Pill
Also known as	Envarsus
Sponsor	Edward Geissler
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Evaluaion the Short Term Effects of Advograf Plus Rapamiune After Kidney Transplantation (NA)
Leveraging Technology to Improve Medication Adherence in Youth With Kidney or Liver Transplant (NA)
Bioavailability and Practicability of Envarsus Versus Advagraf in Liver Transplant Recipients (PHASE4)
Envarsus on the Effect of Total Tacrolimus Dose/Trough Level Ratio on Renal Function (eGFR) in Kidney Transplantation (PHASE4)
Effectiveness of Mycophenolate Mofetil Combined With Tacrolimus for Steroid Tapering in Systemic Lupus Erythematosus (PHASE4)
Tacrolimus C:D Ratio Measured in Renal Transplant Recipients Treated With Once-daily Prolonged-release Drugs (PHASE4)
Allo HSCT Using RIC for Hematological Diseases (PHASE2)
Allogeneic Hematopoietic Stem Cell Transplantation With Ixazomib for High Risk Multiple Myeloma (BMT CTN 1302) (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results